132 related articles for article (PubMed ID: 34517057)
1. Tumor-targeted hyaluronic acid-mPEG modified nanostructured lipid carriers for cantharidin delivery: An in vivo and in vitro study.
Sun S; Shang E; Ju A; Li Y; Wu Q; Li Q; Yang Y; Guo Y; Yang D; Lv S
Fitoterapia; 2021 Nov; 155():105033. PubMed ID: 34517057
[TBL] [Abstract][Full Text] [Related]
2. Enhanced anticancer efficacy of cantharidin by mPEG-PLGA micellar encapsulation: An effective strategy for application of a poisonous traditional Chinese medicine.
Yao H; Zhao J; Wang Z; Lv J; Du G; Jin Y; Zhang Y; Song S; Han G
Colloids Surf B Biointerfaces; 2020 Dec; 196():111285. PubMed ID: 32771818
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid derivative-modified nano-structured lipid carrier for cancer targeting and therapy.
Liu X; Liu H; Wang SL; Liu JW
J Zhejiang Univ Sci B; 2020 Jul; 21(7):571-580. PubMed ID: 32633111
[TBL] [Abstract][Full Text] [Related]
4. Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy.
Qu CY; Zhou M; Chen YW; Chen MM; Shen F; Xu LM
Int J Nanomedicine; 2015; 10():3911-20. PubMed ID: 26089667
[TBL] [Abstract][Full Text] [Related]
5. Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part II. In vivo biodistribution, pharmacodynamic and hematological toxicity studies.
Negi LM; Talegaonkar S; Jaggi M; Verma AK; Verma R; Dobhal S; Kumar V
Colloids Surf B Biointerfaces; 2014 Nov; 123():610-5. PubMed ID: 25454755
[TBL] [Abstract][Full Text] [Related]
6. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.
Yang XY; Li YX; Li M; Zhang L; Feng LX; Zhang N
Cancer Lett; 2013 Jul; 334(2):338-45. PubMed ID: 22776563
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
Zhang B; Zhang Y; Yu D
Oncol Rep; 2017 Feb; 37(2):937-944. PubMed ID: 27959442
[TBL] [Abstract][Full Text] [Related]
9. Development of 11-DGA-3-
Zhou L; Zou M; Zhu K; Ning S; Xia X
Molecules; 2019 Aug; 24(17):. PubMed ID: 31450608
[TBL] [Abstract][Full Text] [Related]
10. Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma.
Xu Y; Wang M; Ning S; Yang Z; Zhou L; Xia X
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296377
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy.
Liu Q; Li J; Pu G; Zhang F; Liu H; Zhang Y
Drug Deliv; 2016 May; 23(4):1364-8. PubMed ID: 25874959
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation.
Yue Y; Zhao D; Yin Q
Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid-coated nanostructured lipid carriers for loading multiple traditional Chinese medicine components for liver cancer treatment.
Sun S; Guan Q; Shang E; Xiao H; Yu X; Shi L; Zhao C; Guo Y; Lv S; Li Y
Pak J Pharm Sci; 2020 Jan; 33(1):109-119. PubMed ID: 32122838
[TBL] [Abstract][Full Text] [Related]
14. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
Su Z; Niu J; Xiao Y; Ping Q; Sun M; Huang A; You W; Sang X; Yuan D
Mol Pharm; 2011 Oct; 8(5):1641-51. PubMed ID: 21770405
[TBL] [Abstract][Full Text] [Related]
15. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
Banerjee P; Geng T; Mahanty A; Li T; Zong L; Wang B
Int J Pharm; 2019 Feb; 557():374-389. PubMed ID: 30610896
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of PEGylated asiatic acid nanostructured lipid carriers on anti-fibrosis effects.
Chen X; Zhang Y; Zhao P; Chen Y; Zhou Y; Wang S; Yin L
Drug Dev Ind Pharm; 2020 Jan; 46(1):57-69. PubMed ID: 31813288
[TBL] [Abstract][Full Text] [Related]
17. Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part I. Synthesis, characterization and in vitro investigation.
Negi LM; Talegaonkar S; Jaggi M; Verma AK; Verma R; Dobhal S; Kumar V
Colloids Surf B Biointerfaces; 2014 Nov; 123():600-9. PubMed ID: 25454761
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy.
Lu Z; Su J; Li Z; Zhan Y; Ye D
Drug Dev Ind Pharm; 2017 Jan; 43(1):160-170. PubMed ID: 27553814
[TBL] [Abstract][Full Text] [Related]
19. Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer.
Kebebe D; Wu Y; Zhang B; Yang J; Liu Y; Li X; Ma Z; Lu P; Liu Z; Li J
Int J Nanomedicine; 2019; 14():6179-6195. PubMed ID: 31447559
[No Abstract] [Full Text] [Related]
20. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S
Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
